Showing results (581-590 of 729) with videos related to

Sort By:
Pageof 73
Molecular Cancer Therapeutics|February 4, 2021
ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of RET, VEGFR2, and IGFBP2Rozita Bagheri-Yarmand, Ramona Dadu, Lei Ye, et al.
Menopause (New York, N.Y.)|August 5, 1998
Management of postmenopausal osteoporosis for primary careP Miller, B Lukert, S Broy, et al.
The Journal of Clinical Endocrinology and Metabolism|August 4, 2005
Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomantAriel L Barkan, Pia Burman, David R Clemmons, et al.
Journal of Intensive Care Medicine|October 25, 2019
Nonocclusive Mesenteric Ischemia and Interventional Local Vasodilatory Therapy: A Meta-Analysis and Systematic Review of the LiteratureKlaus Stahl, Nina Rittgerodt, Markus Busch, et al.
Journal of Intensive Care Medicine|March 27, 2019
A Retrospective Analysis of Nonocclusive Mesenteric Ischemia in Medical and Surgical ICU Patients: Clinical Data on Demography, Clinical Signs, and SurvivalKlaus Stahl, Markus Busch, Sabine K Maschke, et al.
Thyroid : Official Journal of the American Thyroid Association|May 28, 2009
Medullary thyroid cancer: management guidelines of the American Thyroid Association, Richard T Kloos, Charis Eng, et al.
Thyroid : Official Journal of the American Thyroid Association|September 10, 2016
Role of CDKN2C Copy Number in Sporadic Medullary Thyroid CarcinomaElizabeth G Grubbs, Michelle D Williams, Paul Scheet, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 11, 2003
Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationshipLinwah Yip, Gilbert J Cote, Suzanne E Shapiro, et al.
Nature Communications|June 27, 2022
Osteocyte CIITA aggravates osteolytic bone lesions in myelomaHuan Liu, Jin He, Rozita Bagheri-Yarmand, et al.
BMC Cancer|March 7, 2006
[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility studyBernd Gagel, Patrick Reinartz, Cengiz Demirel, et al.
Pageof 73